packageDegarelix

degarelix

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Degarelix is a hormone antagonist used to treat prostate cancer. It is approved and authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q1182795 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:degarelix
ATC codes:L02BX02
DrugBank:DB06699
PubChem CID:16136245
ChEBI:135961
Wikidata:Q1182795
formula:C82H103ClN18O16
molar mass:1632.29 g/mol (PubChem CID 16136245)
logP:3.5 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown